Seeking Alpha

Cell Therapeutics (CTIC) rockets 24%, although it's hard to work out why. The stock's been...

Cell Therapeutics (CTIC) rockets 24%, although it's hard to work out why. The stock's been fairly volatile over the past few months, and often seems to receive a big lift on news of Pixuvri, its treatment of aggressive non-Hodgkin B-cell lymphomas.
Comments (3)
  • grateful908
    , contributor
    Comments (83) | Send Message
     
    RUN FROM THIS STOCK !!!!!!!!
    8 Jan 2013, 10:13 AM Reply Like
  • ted lujan
    , contributor
    Comments (834) | Send Message
     
    WHY
    8 Jan 2013, 02:28 PM Reply Like
  • ted lujan
    , contributor
    Comments (834) | Send Message
     
    Why!!!!!!!
    8 Jan 2013, 02:29 PM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs